tm
Seeing Is Believing
tm
Seeing Is Believing
SMMT is currently covered by 2 analysts with an average price target of $36.96. This is a potential upside of $13.62 (58.35%) from yesterday's end of day stock price of $23.34.
Summit Therapeutics PLC's activity chart (see below) currently has 26 price targets and 25 ratings on display. The stock rating distribution of SMMT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 66.25% with an average time for these price targets to be met of 631 days.
Highest price target for SMMT is $44, Lowest price target is $40, average price target is $42.
Most recent stock forecast was given by DEBJIT CHATTOPADHYAY from GUGGENHEIM on 04-Sep-2025. First documented stock forecast 19-Mar-2020.
Currently out of the existing stock ratings of SMMT, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$40
$18.57 (86.65%)
1 months 5 days ago
(04-Sep-2025)
1/2 (50%)
$16.2 (68.07%)
2419
Buy
$44
$22.57 (105.32%)
$44
3 months 8 days ago
(01-Jul-2025)
4/10 (40%)
$22.8 (107.55%)
15
Hold
$19
$-2.43 (-11.34%)
$19
1 years 12 days ago
(27-Sep-2024)
4/4 (100%)
$-1.89 (-9.05%)
34
Buy
$40
$18.57 (86.65%)
$25
1 years 14 days ago
(25-Sep-2024)
3/4 (75%)
$17.36 (76.68%)
56
What is SMMT (Summit Therapeutics PLC) average time for price targets to be met?
Which analyst has the current highest performing score on SMMT (Summit Therapeutics PLC) with a proven track record?
Which analyst has the current lower performing score on SMMT (Summit Therapeutics PLC) with a proven track record?
Which analyst has the most public recommendations on SMMT (Summit Therapeutics PLC)?
Which analyst is the currently most bullish on SMMT (Summit Therapeutics PLC)?
Which analyst is the currently most reserved on SMMT (Summit Therapeutics PLC)?
